BioUtah Presents at Medical Korea 2026
March 27, 2026
BioUtah president & CEO, Kelvyn Cullimoire, was invited by the Korean Health Industry Development Institute (KHIDI), an agency of the Korean Ministry of Health, to present at the Medical Korea conference on March 19-20, 2026. The topic of Cullimore’s presentation was “Why Utah is a preferred landing place for Korean medical device companies desiring to access the U.S. Market”. Cullimore also participated in a roundtable with key government, economic developement and industry representatives. Medical Korea is a major conference focusing on global business and attracting over 6,000 attendees from 50 countries.
BioUtah signed an MOU with KHIDI in November at the Utah Life Sciences Summit. Also attending was Seth Egan from Co-Diagnostics and Jihyun Kim & Tong-Soo Chung of World Trade Center Utah’s Korean office. The word on Utah as a sifnificant biotech hub is spreading worldwide.
Recent News
- Collaboration with Quest Diagnostics to expand kidneyintelX.dkd TM testing in the United States
- Utah Business Innovation Awards Summit Recap
- Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
- Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
